MX2009004947A - Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6). - Google Patents

Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).

Info

Publication number
MX2009004947A
MX2009004947A MX2009004947A MX2009004947A MX2009004947A MX 2009004947 A MX2009004947 A MX 2009004947A MX 2009004947 A MX2009004947 A MX 2009004947A MX 2009004947 A MX2009004947 A MX 2009004947A MX 2009004947 A MX2009004947 A MX 2009004947A
Authority
MX
Mexico
Prior art keywords
pyrrolidines
arylsulfonyl
inhibitors
compounds
formula
Prior art date
Application number
MX2009004947A
Other languages
English (en)
Inventor
Francisco Javier Lopez-Tapia
Dov Nitzan
Lee Edwin Lowrie Jr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009004947A publication Critical patent/MX2009004947A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Esta invención se refiere a compuestos de pirrolidina sustituida de la fórmula I: (ver fórmula (I)) en la que m, n, Ar, R1 y R2 tienen los significados definidos en esta solicitud. Se describen métodos para la obtención de los compuestos y la utilización de los compuestos.
MX2009004947A 2006-11-09 2007-11-02 Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6). MX2009004947A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85810606P 2006-11-09 2006-11-09
PCT/EP2007/061813 WO2008055847A1 (en) 2006-11-09 2007-11-02 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors

Publications (1)

Publication Number Publication Date
MX2009004947A true MX2009004947A (es) 2009-05-19

Family

ID=39023536

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004947A MX2009004947A (es) 2006-11-09 2007-11-02 Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).

Country Status (18)

Country Link
US (1) US7776910B2 (es)
EP (1) EP2081890B1 (es)
JP (1) JP2010509266A (es)
KR (1) KR20090079259A (es)
CN (1) CN101573332A (es)
AR (1) AR063576A1 (es)
AT (1) ATE495153T1 (es)
AU (1) AU2007316688A1 (es)
BR (1) BRPI0718584A2 (es)
CA (1) CA2667710A1 (es)
CL (1) CL2007003190A1 (es)
DE (1) DE602007011962D1 (es)
ES (1) ES2358549T3 (es)
IL (1) IL198322A0 (es)
MX (1) MX2009004947A (es)
PE (1) PE20081160A1 (es)
TW (1) TW200827337A (es)
WO (1) WO2008055847A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8987307B2 (en) 2011-03-03 2015-03-24 Hoffmann-La Roche Inc. 3-amino-pyridines as GPBAR1 agonists
CN104203935A (zh) 2012-04-04 2014-12-10 霍夫曼-拉罗奇有限公司 作为gpbar1调节剂的1，2-哒嗪，1，6-哒嗪或嘧啶-苯甲酰胺衍生物
CN104557726B (zh) * 2013-10-19 2019-05-24 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
US9663498B2 (en) 2013-12-20 2017-05-30 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic compounds and their application in pharmaceuticals
CN105566182B (zh) * 2016-02-24 2018-02-13 苏州天马精细化学品股份有限公司 一种2‑氨基‑4‑（乙磺酰基）苯酚的合成方法
CN108689904B (zh) * 2017-04-12 2022-06-17 轩竹生物科技股份有限公司 手性杂环叔醇中间体的制备方法及其应用
CN109232362B (zh) * 2017-07-10 2022-12-27 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
KR102639231B1 (ko) * 2017-10-30 2024-02-22 뉴로포레 테라피스, 인코포레이티드 치환된 페닐 설폰일 페닐 트리아졸 싸이온 및 이의 용도
CN109912487B (zh) * 2019-03-25 2023-01-10 山东理工大学 一种合成1-对甲苯磺酰基-2-乙烯基-1氢-吡咯的方法
WO2021076886A1 (en) 2019-10-18 2021-04-22 The Regents Of The University Of California 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE236136T1 (de) * 1998-01-16 2003-04-15 Hoffmann La Roche Benzosulfonderivate
US20040014966A1 (en) * 2000-06-20 2004-01-22 Jacobsen Eric Jon Bis-arylsulfones
PE20020063A1 (es) 2000-06-20 2002-01-30 Upjohn Co Bis-arilsulfonas como ligandos del receptor de 5-ht
MXPA05004128A (es) * 2002-10-18 2005-06-22 Hoffmann La Roche 4-piperazinil bencenosulfonil indoles con afinidad al receptor 5-hidroxitriptamina 6 (5-ht6).
EP1597256A1 (en) * 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
WO2005014578A1 (en) * 2003-08-08 2005-02-17 Glaxo Group Limited Phenylsulfonyl compounds as antipsychotic agents
MX2008002158A (es) * 2005-08-15 2008-04-19 Wyeth Corp Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6.
EP2029528A1 (en) * 2006-04-19 2009-03-04 Abbott GmbH & Co. KG Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor

Also Published As

Publication number Publication date
CA2667710A1 (en) 2008-05-15
PE20081160A1 (es) 2008-08-15
IL198322A0 (en) 2010-02-17
JP2010509266A (ja) 2010-03-25
ES2358549T3 (es) 2011-05-11
BRPI0718584A2 (pt) 2014-03-11
WO2008055847A1 (en) 2008-05-15
KR20090079259A (ko) 2009-07-21
US20080167361A1 (en) 2008-07-10
EP2081890A1 (en) 2009-07-29
ATE495153T1 (de) 2011-01-15
TW200827337A (en) 2008-07-01
CN101573332A (zh) 2009-11-04
AR063576A1 (es) 2009-02-04
CL2007003190A1 (es) 2008-06-27
DE602007011962D1 (en) 2011-02-24
US7776910B2 (en) 2010-08-17
AU2007316688A1 (en) 2008-05-15
EP2081890B1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
MX2009004947A (es) Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
MY150596A (en) Hsp90 inhibitors
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MY150542A (en) Cmet inhibitors
SG171593A1 (en) Inhibitors of c-fms kinase
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
GB0508318D0 (en) Organic compounds
MX2008014004A (es) 1h-benzimidazol-4-carboxamidas sustituidas son inhibidores de parp potentes.
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
TNSN08191A1 (en) Kinase inhibitors
NO20090994L (no) 2-aminobenzoxazol karboxamider som 5HT3 modulatorer
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration